The global fertility enhancing treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of couples who are opting for fertility treatments due to various reasons such as infertility, age-related infertility, and other factors. The increasing awareness about fertility enhancing treatments among people has also led to an increase in the adoption rate of these treatments.
The global fertility enhancing treatment market is segmented on the basis of type into fertility drugs for women, fertility drugs for men, OTC conception gels/lubricants and others; by application into hospitals and drug stores; and by region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
2) Increasing number of women in reproductive age group 3) Technological advancements in fertility treatments such as IVF and ICSI.
Some Of The Growth Factors Of This Market:
- In addition, technological advancements in fertility treatments such as IVF and ICSI are also contributing to the growth of this market globally.
Industry Growth Insights published a new data on “Fertility Enhancing Treatment Market”. The research report is titled “Fertility Enhancing Treatment Market research by Types (Fertility Drugs for Women, Fertility Drugs for Men, OTC Conception Gels/Lubricants, Fertility Enhancing Treatmen), By Applications (Hospitals, Drug Stores, Online), By Players/Companies Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church?Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, The YES YES Company, Fertility Enhancing Treatmen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fertility Enhancing Treatment Market Research Report
By Type
Fertility Drugs for Women, Fertility Drugs for Men, OTC Conception Gels/Lubricants, Fertility Enhancing Treatmen
By Application
Hospitals, Drug Stores, Online
By Companies
Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church?Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, The YES YES Company, Fertility Enhancing Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Fertility Enhancing Treatment Market Report Segments:
The global Fertility Enhancing Treatment market is segmented on the basis of:
Types
Fertility Drugs for Women, Fertility Drugs for Men, OTC Conception Gels/Lubricants, Fertility Enhancing Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Drug Stores, Online
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Ferring
- MSD
- LIVZON
- Abbott
- Bayer Zydus Pharma
- Church?Dwight
- SASMAR
- BioFilm,Inc
- FAIRHAVEN HEALTH
- The YES YES Company
- Fertility Enhancing Treatmen
Highlights of The Fertility Enhancing Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fertility Drugs for Women
- Fertility Drugs for Men
- OTC Conception Gels/Lubricants
- Fertility Enhancing Treatmen
- By Application:
- Hospitals
- Drug Stores
- Online
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fertility Enhancing Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fertility enhancing treatment is a term used to describe any medical or surgical procedure that can improve fertility. This includes treatments such as in vitro fertilization (IVF), assisted reproductive technology (ART) such as intrauterine insemination (IUI), and gamete intrafallopian transfer (GIFT).
Some of the key players operating in the fertility enhancing treatment market are Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church?Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, The YES YES Company, Fertility Enhancing Treatmen.
The fertility enhancing treatment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fertility Enhancing Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fertility Enhancing Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fertility Enhancing Treatment Market - Supply Chain
4.5. Global Fertility Enhancing Treatment Market Forecast
4.5.1. Fertility Enhancing Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fertility Enhancing Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fertility Enhancing Treatment Market Absolute $ Opportunity
5. Global Fertility Enhancing Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fertility Enhancing Treatment Market Size and Volume Forecast by Type
5.3.1. Fertility Drugs for Women
5.3.2. Fertility Drugs for Men
5.3.3. OTC Conception Gels/Lubricants
5.3.4. Fertility Enhancing Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fertility Enhancing Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fertility Enhancing Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Drug Stores
6.3.3. Online
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fertility Enhancing Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fertility Enhancing Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fertility Enhancing Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fertility Enhancing Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fertility Enhancing Treatment Demand Share Forecast, 2019-2026
9. North America Fertility Enhancing Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fertility Enhancing Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fertility Enhancing Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Drug Stores
9.4.3. Online
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fertility Enhancing Treatment Market Size and Volume Forecast by Type
9.7.1. Fertility Drugs for Women
9.7.2. Fertility Drugs for Men
9.7.3. OTC Conception Gels/Lubricants
9.7.4. Fertility Enhancing Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fertility Enhancing Treatment Demand Share Forecast, 2019-2026
10. Latin America Fertility Enhancing Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fertility Enhancing Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fertility Enhancing Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Drug Stores
10.4.3. Online
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fertility Enhancing Treatment Market Size and Volume Forecast by Type
10.7.1. Fertility Drugs for Women
10.7.2. Fertility Drugs for Men
10.7.3. OTC Conception Gels/Lubricants
10.7.4. Fertility Enhancing Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fertility Enhancing Treatment Demand Share Forecast, 2019-2026
11. Europe Fertility Enhancing Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fertility Enhancing Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fertility Enhancing Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Drug Stores
11.4.3. Online
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fertility Enhancing Treatment Market Size and Volume Forecast by Type
11.7.1. Fertility Drugs for Women
11.7.2. Fertility Drugs for Men
11.7.3. OTC Conception Gels/Lubricants
11.7.4. Fertility Enhancing Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fertility Enhancing Treatment Demand Share, 2019-2026
12. Asia Pacific Fertility Enhancing Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fertility Enhancing Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fertility Enhancing Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Drug Stores
12.4.3. Online
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fertility Enhancing Treatment Market Size and Volume Forecast by Type
12.7.1. Fertility Drugs for Women
12.7.2. Fertility Drugs for Men
12.7.3. OTC Conception Gels/Lubricants
12.7.4. Fertility Enhancing Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fertility Enhancing Treatment Demand Share, 2019-2026
13. Middle East & Africa Fertility Enhancing Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fertility Enhancing Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fertility Enhancing Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Drug Stores
13.4.3. Online
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fertility Enhancing Treatment Market Size and Volume Forecast by Type
13.7.1. Fertility Drugs for Women
13.7.2. Fertility Drugs for Men
13.7.3. OTC Conception Gels/Lubricants
13.7.4. Fertility Enhancing Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fertility Enhancing Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fertility Enhancing Treatment Market: Market Share Analysis
14.2. Fertility Enhancing Treatment Distributors and Customers
14.3. Fertility Enhancing Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ferring
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MSD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LIVZON
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bayer Zydus Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Church?Dwight
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SASMAR
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BioFilm,Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. FAIRHAVEN HEALTH
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. The YES YES Company
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Fertility Enhancing Treatmen
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
